Lv11
42 积分 2023-12-19 加入
An evaluation of patritumab deruxtecan for the treatment of EGFR -mutated non-small cell lung cancer
2个月前
已完结
An evaluation of elranatamab for the treatment of myeloma: current evidence for treating relapsed/refractory disease and future directions
2个月前
已关闭
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck: A Multicenter, Phase IIa Trial
2个月前
已完结
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study
3个月前
已完结
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study
3个月前
已关闭
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
4个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
4个月前
已完结
Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer
5个月前
已完结
Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer
5个月前
已完结
皖公网安备34019202002308
